AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $47.75M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| TZN | Ann: 1st Quarter Report | 19/04/18 | 0 | 138 | |||
|
|||||||
| TZN | Ann: Appendix 3B | 04/04/18 | 0 | 91 | |||
|
|||||||
| TZN | Ann: 2017 Annual Report | 29/03/18 | 0 | 100 | |||
|
|||||||
| TZN | Ann: Appendix 4G | 29/03/18 | 0 | 68 | |||
|
|||||||
| TZN | Ann: Corporate Governance Statement | 29/03/18 | 0 | 76 | |||
|
|||||||
| TZN | Ann: THR: KAPUNDA COPPER HIGH GRADE ZONE | 20/03/18 | 0 | 116 | |||
|
|||||||
| TZN | Ann: Appendix 4E - Preliminary Final Report | 28/02/18 | 0 | 140 | |||
|
|||||||
See All Discussions
ASX News